Vitor Roque

BD (Becton, Dickinson and Company), a leading global medical technology company, has appointed Vitor Roque as Executive Vice President and Chief Financial Officer (CFO).
Roque had been serving as Interim CFO since December 2025 and now assumes the role on a permanent basis.

Roque brings more than 25 years of experience at BD, having held a variety of senior finance and operations leadership positions across the organization. Most recently, he served as Senior Vice President, Finance and Corporate Financial Planning and Analysis. During his tenure as Interim CFO, he led the company's global finance organization and played a key role in advancing strategic priorities under the New BD strategy, including the successful completion of the separation of BD's Biosciences & Diagnostic Solutions business ahead of schedule.

Throughout his career at BD, Roque has built extensive expertise in financial management, operations, manufacturing, and business unit leadership. His deep understanding of the company's global portfolio, operating model, and international footprint has been shaped by decades of hands-on leadership across multiple functions and regions.

Having lived and worked in several countries, Roque brings valuable global experience and an appreciation for the cultural and regional dynamics that support BD's worldwide operations. His broad perspective and proven execution capabilities are expected to strengthen financial discipline, improve organizational agility, and support the company's continued strategic growth.

Roque's appointment reinforces BD's commitment to strong financial leadership as the company continues to execute its long-term strategy, drive operational excellence, and deliver innovative medical technologies that improve healthcare outcomes worldwide.